Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development

Immunopharmacology and Immunotoxicology
Samra Sardar, Åsa Andersson

Abstract

Development of novel drugs for treatment of chronic inflammatory diseases is to a large extent dependent on the availability of good experimental in vivo models in order to perform preclinical tests of new drugs and for the identification of novel drug targets. Here, we review a number of existing rodent models for Rheumatoid Arthritis in the context of how these models have been utilized for developing established therapy in Rheumatoid Arthritis and, furthermore, the present use of animal models for studies of novel drug candidates. We have studied the literature in the field for the use of in vivo models during development of anti-rheumatic drugs; from Methotrexate to various antibody treatments, to novel drugs that are, or have recently been, in clinical trials. For novel drugs, we have explored websites for clinical trials. Although a single Rheumatoid Arthritis in vivo model cannot mirror the complexity of disease development, there exist a number of good animal models for Rheumatoid Arthritis, each defining some parts in disease development, which are useful for studies of drug response. We find that many of the established drugs were not tested in in vivo models before being used in the clinic, but rather animal models h...Continue Reading

References

Apr 1, 1977·Arthritis and Rheumatism·D BrackertzI R Mackay
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G J ThorbeckeM A Palladino
Jan 1, 1989·Advances in Enzyme Regulation·S S Kerwar, A L Oronsky
Jul 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R HolmdahlJ Mo
Jun 1, 1989·Agents and Actions·B D JaffeeN R Ackerman
Jan 1, 1988·Methods in Enzymology·J D TaurogR A McReynolds
Jul 1, 1987·Annals of the Rheumatic Diseases·K YamakiS Tsurufuji
Apr 1, 1986·Annals of the Rheumatic Diseases·K TakagishiK Arai
Nov 1, 1968·Annals of the Rheumatic Diseases·J D Jessop, H L Currey
Aug 1, 1982·Arthritis and Rheumatism·D E Trentham
Nov 1, 1995·British Journal of Rheumatology·G Smedegård, J Björk
Feb 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·K ThossR Brauer
Nov 29, 1996·Cell·V KouskoffD Mathis
Mar 28, 1998·The Journal of Experimental Medicine·T AlonziG Ciliberto
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·S OhshimaT Kishimoto
Jun 17, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A WilliamsB Williams
Oct 29, 2000·Annals of the Rheumatic Diseases·N NishimotoK Yoshizaki
Mar 13, 2001·Annual Review of Immunology·M Feldmann, R N Maini
May 9, 2001·The Journal of Clinical Investigation·Y NikiN Tada
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B T Wipke, P M Allen
Nov 21, 2001·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·S SakumaT Goto
May 16, 2002·Arthritis Research·Tetsuji Naka, Tadamitsu Kishimoto

❮ Previous
Next ❯

Citations

Oct 5, 2019·Laboratory Animals·Chuang GeHanmei Xu
Jul 2, 2017·Arthritis Research & Therapy·Bradford D FischerAndrea Bottaro
Jan 12, 2019·Arthritis Research & Therapy·Samra SardarÅsa Andersson
Jun 9, 2020·Frontiers in Immunology·Kim R van DaalenNiels Bovenschen
Sep 17, 2019·Bioconjugate Chemistry·Sangita KhatriKira Astakhova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved